Reconstruction Meshes are surgically implantable woven sheets that are used to repair or support organs and other tissues. The meshes are made either from synthetic material and/or bioengineered from animal tissues. Reconstruction Meshes are generally available in multiple sizes, thicknesses, and pore sizes, however for this market model the meshes are segmented based on the materials used to make them.
The market for breast reconstruction is mainly driven by patients with breast cancer, as that is the most common type of cancer in women. Many breast cancer patients undergo single or double mastectomies, thus requiring breast reconstruction. This population is expected to grow as the global female population ages and the prevalence of mastectomies increases. Breast reconstruction improves the quality of life of patients, such that the number of reconstruction procedures is expected to increase.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are :
Currently marketed Reconstruction Meshes and evolving competitive landscape :
- Insightful review of the key industry trends.
- Annualized total Reconstruction Meshes market revenue by segment and market outlooks from 2015-2033.
- Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights :
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition, The analyst analysts provide unique country specific insights on the market.
- SWOT analysis for Reconstruction Meshes market.
- Competitive dynamics insights and trends provided Reconstruction Meshes market.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Companies covered: Allergan Aesthetics, W. L. Gore & Associates Inc, MTF Biologics, Surgalign Holdings Inc, Coloplast A/S, Ethicon Inc, Boston Scientific Corp, CR Bard Inc, Integra LifeSciences Holdings Corp, pfm medical ag, Baxter International Inc, LifeNet Health Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for :- CMO executives who must have deep understanding of the Reconstruction Meshes market place to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to :
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Reconstruction Meshes.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Reconstruction Meshes market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Reconstruction Meshes market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allergan Aesthetics
- W. L. Gore & Associates Inc
- MTF Biologics
- Surgalign Holdings Inc
- Coloplast A/S
- Ethicon Inc
- Boston Scientific Corp
- CR Bard Inc
- Integra LifeSciences Holdings Corp
- pfm medical ag
- Baxter International Inc
- LifeNet Health Inc